Mexico – Azelis is seeking to strengthen its position in Mexico’s food ingredients and specialty chemical markets with the opening of a new full-service innovation center in Mexico City.
According to a report by FoodBev, Azelis-owned Megafarma will be responsible for the innovation center featuring five industry-specific application labs for Food, Pharma, Plastics, Personal Care and CASE (coatings, adhesives, sealants, elastomers).
Azelis says that application labs will provide custom formulations, product development, regulatory compliance, problem-solving, and sales support to these dynamic and constantly evolving market segments.
The center will also host virtual and live customer seminars, interactive formulation workshops, and hands-on technical training for the company’s sales teams.
With all the amenities that the facility provides, Azelis hopes that its presence will support its strategy to be a leader in sales, technology, and distribution of specialty ingredients and chemicals in the region.
“The opening of this innovation center marks a turning point for Azelis in Mexico,” says Frank Bergonzi, CEO and president, Azelis Americas.
“Azelis can now provide an unsurpassed level of service, technology, and innovative solutions to our customers in the region. Our new state of the art laboratories will deliver on our mission of ‘Innovation through formulation.’”
According to Eduardo Salinas, managing director, Azelis Latin America, the company’s commitment to establishing “a leading position in specialties distribution in Mexico is clear” with the opening of this innovation center.
Last week, Azelis diversified its presence in South Korea through the acquisition MH, a local distributor of food ingredients such as gluten, starches, sweeteners, and functional food ingredients.
Layn Natural Ingredients to expand botanical extract capabilities
Earlier, botanical extract specialist Layn Natural Ingredients announced plans to invest $148 million to expand infrastructure, drive innovation and ensure a globally secure supply chain.
The funds will be invested in a new manufacturing facility which is expected to have the capacity to process an additional 4,000 tonnes of stevia leaf extract per year.
Layn has achieved over 50 patents globally in science and innovation, and the added R&D capabilities in the new facility will also support Layn’s ongoing commitment to the discovery of new botanical extract innovations and science for specific botanical compounds.
Liked this article? Subscribe to Food Business Africa News, our regular email newsletters with the latest news insights from Africa and the World’s food and agro industry. SUBSCRIBE HERE
